This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Parkinson's disease, strict definition (more control exclusions)
PDSTRICT_EXMORE
No definition available.
Endpoint definition
↥
FinnGen phenotype data
individuals
Apply sex-specific rule None
Check conditions None
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
G20
Hospital discharge: ICD-9
3320A
Hospital discharge: ICD-8
34200
Cause of death: ICD-10
G20
Cause of death: ICD-9
3320A
Cause of death: ICD-8
34200
KELA reimbursements: KELA codes
110
KELA reimbursements: ICD-10
G20, G20+F02.39
3 out of 7 registries used, show all original rules.
-
Check minimum number of events None
-
Include endpoints None
-
Remove individuals based on genotype QC
4231
PDSTRICT_EXMORE
Control definitions
Control exclude
G6_PARKINSON, F5_PSYCH, NEURODIS
Extra metadata
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
G20-G26
Name in latin
Morbus Parkinson
No upset plot: script not run.
No upset table: script not run.
Similar endpoints
↥List of similar endpoints to
Parkinson's disease, strict definition (more control exclusions)
based on the number of shared cases.
Broader endpoints:
- Parkinson's disease, strict definition
- Parkinson's disease (more control exclusions)
- Parkinson's disease
- Parkinson's disease, including avohilmo
- Extrapyramidal and movement disorders
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 4231 | 1651 | 2580 |
| Unadjusted prevalence (%) | 1.03 | 0.72 | 1.42 |
| Mean age at first event (years) | 68.75 | 67.72 | 69.41 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: PDSTRICT_EXMORE – Parkinson's disease, strict definition (more control exclusions)
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Parkinson's disease, strict definition (more control exclusions)
↥Endpoint not on priority list, no data to show.